Capdevila J, Pubul V, Anido U, Walter T, et al. A Randomized clinical trial evaluating the impact on survival and quality of life of (177)Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217). BMC Cancer 2025;25:613.
PMID: 40186126